VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study.
Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study. Lancet Oncol. 2018 02; 19(2):240-248.
View in:
PubMed
subject areas
Academic Medical Centers
Aged
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Cancer Care Facilities
Cyclophosphamide
Dexamethasone
Disease-Free Survival
Dose-Response Relationship, Drug
Doxorubicin
Drug Administration Schedule
Female
Geriatric Assessment
Humans
Induction Chemotherapy
Kaplan-Meier Estimate
Male
Middle Aged
Patient Safety
Patient Selection
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prognosis
Proportional Hazards Models
Retrospective Studies
Single-Blind Method
Survival Analysis
Texas
Treatment Outcome
Vincristine
authors with profiles
STEVEN M KORNBLAU
MARINA KONOPLEVA
ALESSANDRA FERRAJOLI
GUILLERMO GARCIA-MANERO
WILLIAM G WIERDA
JOSEPH KHOURY
YESID ALVARADO
JEFFREY L JORGENSEN
ELIAS JOSEPH JABBOUR
TAPAN MAHENDRA KADIA
JAN ANDREAS BURGER
NITIN JAIN
NAVEEN PEMMARAJU
NAVAL DAVER
COURTNEY DINARDO
HAGOP M KANTARJIAN